A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy
NCT: NCT05984238 · COMPLETED
Brief Summary
The objective of this study is to evaluate the safety, feasibility and efficacy of pulsed electric field induced duodenal mucosal regeneration (with the Endogenex System en Gen 2 Device) combined with a GLP-1 receptor agonist (Semaglutide, Ozempic) in subjects with insulin-dependent type 2 diabetes mellitus.
Frequently Asked Questions
What is A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy?
A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy is a clinical trial registered under NCT05984238. Current status: COMPLETED.
What is the status of NCT05984238?
The current status of NCT05984238 (A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy) is: COMPLETED.
When did A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy start?
A Trial to Evaluate Safety, Feasibility and Efficacy of Endoscopic Duodenal PEF Therapy started on 2023-08-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.